Journal
ANTIOXIDANTS & REDOX SIGNALING
Volume 27, Issue 18, Pages 1473-1490Publisher
MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2016.6981
Keywords
Neutrophil cytosolic factor 1 (Ncf1); reactive oxygen species (ROS); IFN-regulated gene expression; interferon signature; collagen-induced arthritis; NADPH oxidase
Funding
- Academy of Finland
- Sigrid Juselius Foundation
- Swedish Foundation for Strategic Research
- National Doctoral Programme in Informational and Structural Biology
- Turku University Foundation
- Knut and Alice Wallenberg Foundation
- King Gustaf V 80-years Foundation
- EU Innovative Medicine initiative
- Swedish Research Council
- European Union's Seventh Framework Programme [Health-F2-2011-278611]
- Finnish Cultural Foundation
- Varsinais-Suomi Regional fund
Ask authors/readers for more resources
Aims: Neutrophil cytosolic factor 1 (NCF1) is a key regulatory component of the phagocytic NOX2 complex, which produces reactive oxygen species (ROS). Polymorphism of the Ncf1 gene is associated with increased arthritis severity. In this study, we generated targeted Ncf1 knock-in mice with inducible Ncf1 expression and determined the critical time window during which the NOX2-derived ROS protect the mice from arthritis. Results: Targeted Ncf1 knock-in mice lacked NOX2-derived ROS, and in vivo allelic conversion of Ncf1 by the CreER(T2) recombinase led to full protein expression and ROS production within 10 days. Mice in which Ncf1 had been activated before immunization with type II collagen (CII) developed only mild clinical symptoms of collagen-induced arthritis (CIA), whereas the ROS-deficient littermates had severe arthritis. The functional Ncf1 restricted the expansion of IL-17A-producing T cells specific for the immunodominant CII peptide. When the Ncf1 gene was activated after the priming phase, Ncf1-dependent protection from autoimmune arthritis was still observed, together with a reduced number of splenic monocytes but it was not associated with alterations in peptide-specific T cell response. The Ncf1-deficient mice expressed pronounced interferon signature, which could be normalized by conditional expression of Ncf1 and was also present in the Ncf1-mutated mouse during arthritis. Innovation and Conclusion: Ncf1 deficiency has been known to predispose to autoimmunity in both humans and rodents. Our in vivo results point to a regulatory role of NOX2-derived ROS not only during priming but also during the effector phase of CIA, most likely via different mechanisms.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available